Altered amygdala volumes and microstructure in focal epilepsy patients with tonic-clonic seizures, ictal, and post-convulsive central apnea.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
Dec 2023
Historique:
revised: 16 10 2023
received: 11 06 2023
accepted: 16 10 2023
medline: 17 12 2023
pubmed: 20 10 2023
entrez: 19 10 2023
Statut: ppublish

Résumé

Sudden unexpected death in epilepsy (SUDEP) is a leading cause of death for patients with epilepsy; however, the pathophysiology remains unclear. Focal-to-bilateral tonic-clonic seizures (FBTCS) are a major risk factor, and centrally-mediated respiratory depression may increase the risk further. Here, we determined the volume and microstructure of the amygdala, a key structure that can trigger apnea in people with focal epilepsy, stratified by the presence or absence of FBTCS, ictal central apnea (ICA), and post-convulsive central apnea (PCCA). Seventy-three patients with focal impaired awareness seizures without FBTC seizures (FBTCneg group) and 30 with FBTCS (FBTCpos group) recorded during video electroencephalography (VEEG) with respiratory monitoring were recruited prospectively during presurgical investigations. We acquired high-resolution T1-weighted anatomic and multi-shell diffusion images, and computed neurite orientation dispersion and density imaging (NODDI) metrics in all patients with epilepsy and 69 healthy controls. Amygdala volumetric and microstructure alterations were compared between three groups: healthy subjects, FBTCneg and FBTCpos groups. The FBTCpos group was further subdivided by the presence of ICA and PCCA, verified by VEEG. Bilateral amygdala volumes were significantly increased in the FBTCpos cohort compared to healthy controls and the FBTCneg group. Patients with recorded PCCA had the highest increase in bilateral amygdala volume of the FBTCpos cohort. Amygdala neurite density index (NDI) values were decreased significantly in both the FBTCneg and FBTCpos groups relative to healthy controls, with values in the FBTCpos group being the lowest of the two. The presence of PCCA was associated with significantly lower NDI values vs the non-apnea FBTCpos group (p = 0.004). Individuals with FBTCpos and PCCA show significantly increased amygdala volumes and disrupted architecture bilaterally, with greater changes on the left side. The structural alterations reflected by NODDI and volume differences may be associated with inappropriate cardiorespiratory patterns mediated by the amygdala, particularly after FBTCS. Determination of amygdala volumetric and architectural changes may assist identification of individuals at risk.

Identifiants

pubmed: 37857465
doi: 10.1111/epi.17804
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3307-3318

Subventions

Organisme : NINDS NIH HHS
ID : NS090405
Pays : United States
Organisme : NINDS NIH HHS
ID : U01-NS090407
Pays : United States
Organisme : Medical Research Council
ID : G0802012 MR/M00841X/1
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : NS090405
Pays : United States
Organisme : NINDS NIH HHS
ID : U01-NS090407
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

Neuroimage Clin. 2019;24:102060
pubmed: 31722289
Handb Clin Neurol. 2018;151:119-140
pubmed: 29519455
Nat Rev Neurol. 2009 Sep;5(9):492-504
pubmed: 19668244
Spinal Cord. 2019 Mar;57(3):206-213
pubmed: 30185892
Epilepsia. 2019 Apr;60(4):718-729
pubmed: 30868560
J Mol Psychiatry. 2013 Jun 05;1(1):9
pubmed: 25408902
Neuroimage. 2012 Feb 1;59(3):2678-88
pubmed: 21914485
Epilepsia. 2023 Dec;64(12):3307-3318
pubmed: 37857465
Epilepsy Res. 2008 Feb;78(2-3):102-16
pubmed: 18226499
Neurology. 2017 Feb 14;88(7):701-705
pubmed: 28087822
Transl Psychiatry. 2017 Aug 8;7(8):e1194
pubmed: 28786979
Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):450-6
pubmed: 15854157
J Neurotrauma. 2010 Nov;27(11):2033-40
pubmed: 20822462
Epilepsy Res. 2019 Oct;156:106164
pubmed: 31330483
J Comp Neurol. 2000 Feb 7;417(2):195-204
pubmed: 10660897
Prog Neurobiol. 2022 Jul;214:102283
pubmed: 35533810
J Neurosci Methods. 2020 Dec 1;346:108908
pubmed: 32814118
Eur Heart J. 1998 Jun;19 Suppl F:F72-80
pubmed: 9651739
Learn Mem. 2004 May-Jun;11(3):261-6
pubmed: 15169855
Funct Neurol. 2017 Apr/Jun;32(2):97-101
pubmed: 28676143
Neurology. 2019 Jan 15;92(3):e171-e182
pubmed: 30568003
Neurology. 1992 Sep;42(9):1727-32
pubmed: 1513461
Nat Neurosci. 2012 Mar 18;15(4):528-36
pubmed: 22426254
Ann Neurol. 2018 Mar;83(3):460-471
pubmed: 29420859
Forensic Sci Int. 2012 Nov 30;223(1-3):171-5
pubmed: 22999232
Epilepsy Behav. 2016 Jul;60:33-41
pubmed: 27176882
Clin Exp Pharmacol Physiol. 1998 Jun;25(6):483-6
pubmed: 9673830
Neuroimage. 2003 Oct;20(2):870-88
pubmed: 14568458
Exp Neurol. 1985 Oct;90(1):173-86
pubmed: 4043291
Brain Res. 1984 Jul 23;306(1-2):1-8
pubmed: 6466967
Front Neurol. 2019 Mar 01;10:166
pubmed: 30890997
Lancet Neurol. 2013 Oct;12(10):966-77
pubmed: 24012372
J Neurosci. 2015 Jul 15;35(28):10281-9
pubmed: 26180203
Epilepsy Res. 2023 May;192:107139
pubmed: 37068421
Brain Res Brain Res Rev. 2003 Jan;41(1):88-123
pubmed: 12505650
Prog Neurobiol. 2021 Jan;196:101891
pubmed: 32730859
Brain. 2015 Oct;138(Pt 10):2907-19
pubmed: 26264515
Neuroimage. 2005 Feb 1;24(3):751-62
pubmed: 15652310
Neuroimage. 2012 Jul 16;61(4):1000-16
pubmed: 22484410
Clin Auton Res. 2006 Feb;16(1):6-11
pubmed: 16477489
Epilepsia. 2005 Nov;46(11):1724-43
pubmed: 16302852
Epilepsia. 2018 Mar;59(3):573-582
pubmed: 29336036
Epilepsia. 2020 Jun;61(6):1253-1260
pubmed: 32391925
Neuroimage. 2021 Dec 15;245:118749
pubmed: 34852276
J Clin Neurophysiol. 2012 Oct;29(5):356-65
pubmed: 23027091
Physiol Rev. 1994 Apr;74(2):323-64
pubmed: 8171117
Epilepsia. 2020 Aug;61(8):1570-1580
pubmed: 32683693
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Neuroimage. 2016 Jan 15;125:1063-1078
pubmed: 26481672
Neuroimage. 2004;23 Suppl 1:S69-84
pubmed: 15501102
JAMA Neurol. 2018 Feb 1;75(2):194-202
pubmed: 29181526
Exp Brain Res. 1978 Aug 15;32(4):529-47
pubmed: 689127
Circulation. 1987 Jul;76(1 Pt 2):I2-9
pubmed: 3297404
Epilepsia. 2020 Jan;61(1):70-80
pubmed: 31828789

Auteurs

Claudia Zeicu (C)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK.

Antoine Legouhy (A)

Centre for Medical Image Computing and Department of Computer Science, University College London, London, UK.

Catherine A Scott (CA)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK.
Department of Clinical Neurophysiology, University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, UK.

Joana F A Oliveira (JFA)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK.
Department of Clinical Neurophysiology, University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, UK.

Gavin P Winston (GP)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK.
Epilepsy Society MRI Unit, Chalfont St Peter, UK.
Department of Medicine, Division of Neurology, Queen's University, Kingston, Ontario, Canada.

John S Duncan (JS)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK.

Sjoerd B Vos (SB)

Centre for Medical Image Computing and Department of Computer Science, University College London, London, UK.
Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, UK.
Centre for Microscopy, Characterisation, and Analysis, The University of Western Australia, Nedlands, Western Australia, Australia.

Maria Thom (M)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK.

Samden Lhatoo (S)

Department of Neurology, University of Texas Health Sciences Center at Houston, Houston, Texas, USA.

Hui Zhang (H)

Centre for Medical Image Computing and Department of Computer Science, University College London, London, UK.

Ronald M Harper (RM)

Brain Research Institute, University of California at Los Angeles, Los Angeles, California, USA.
Department of Neurobiology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.

Beate Diehl (B)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK.
Department of Clinical Neurophysiology, University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH